Biomet, Inc. Announces New Chief Financial Officer
2007年5月15日 - 4:06AM
ビジネスワイヤ(英語)
Biomet, Inc. (NASDAQ:BMET) today announced that Daniel P. Florin
will join Biomet as Senior Vice President and Chief Financial
Officer effective June 5, 2007. Mr. Florin is currently Vice
President and Corporate Controller for Boston Scientific
Corporation where he has held that position for the past six years.
He has 16 years of financial officer/controller experience in the
medical device industry and five years of public accounting and
auditing experience. Since July 1995, Mr. Florin served in
financial leadership positions within Boston Scientific Corporation
and its various business units prior to being appointed as
Corporate Controller in 2001. From October 1990 to July 1995 he
served in a number of finance, accounting and leadership positions
for C.R. Bard, Inc. He began his career in the audit services
practice of Deloitte & Touche in New Jersey. Mr. Florin
received a bachelors degree of business administration, with a
concentration in accounting, from the University of Notre Dame and
an executive masters degree in business administration from Boston
University. He is also a certified public accountant and member of
the American Institute of Certified Public Accountants. �We are
pleased to have Dan fill this important role, as he brings with him
a strong financial, public company and SEC reporting background as
well as demonstrated ability to manage complex medical device
organizations. We believe the depth and breadth of his experiences
have prepared him well for his new responsibilities� said Jeffrey
R. Binder, President and Chief Executive Officer of Biomet. �I am
very excited to be joining Biomet at this time,� said Mr. Florin.
�I look forward to helping Biomet strengthen its financial
organization, efficiency and responsiveness and provide the
necessary leadership that is fundamental to achieving Biomet�s
financial and operational goals.� J. Pat Richardson, currently
Interim Chief Financial Officer and Treasurer, will continue in his
role as Biomet�s Vice President�Finance once Mr. Florin begins his
employment on June 5, 2007. About Biomet Biomet, Inc. and its
subsidiaries design, manufacture and market products used primarily
by musculoskeletal medical specialists in both surgical and
non-surgical therapy. Biomet�s product portfolio encompasses
reconstructive products, including orthopedic joint replacement
devices, bone cements and accessories, and dental reconstructive
implants; fixation products, including electrical bone growth
stimulators, internal and external orthopedic fixation devices,
craniomaxillofacial implants and bone substitute materials; spinal
products, including spinal stimulation devices, spinal hardware and
orthobiologics; and other products, such as arthroscopy products
and softgoods and bracing products. Headquartered in Warsaw,
Indiana, Biomet and its subsidiaries currently distribute products
in more than 100 countries. Forward-Looking Statements This press
release contains certain statements that are �forward-looking
statements� within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934, as
amended. Such statements are qualified by the inherent risks and
uncertainties surrounding future expectations generally, and also
may materially differ from actual future experience involving any
one or more of such statements. Such risks and uncertainties
include our ability to develop and market new products and
technologies in a timely manner, the effect of the pending merger
on Biomet�s business and its relationship with customers,
distributors, employees and suppliers and the risk factors as set
forth from time to time in Biomet�s filings with the SEC. The
inclusion of a forward-looking statement herein should not be
regarded as a representation by Biomet that Biomet�s objectives
will be achieved. Biomet undertakes no obligation to publicly
update forward-looking statements, whether as a result of new
information, future events or otherwise.
Biomet (NASDAQ:BMET)
過去 株価チャート
から 8 2024 まで 9 2024
Biomet (NASDAQ:BMET)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Biomet (MM) (ナスダック市場): 0 recent articles
その他のBiomet, Inc.ニュース記事